Levetiracetam Injection
Product Images NDC 0143-9574

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 0143-9574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levetiracetam Injection Novaplus 1)

FDA Label Image

Ndc 0143-9574-25 Rx Only Levetiracetam Injection For Iv Use Only 500 mg/5 mL (100 mg/ml) Must Be Diluted Prior To Administration 25 X 5 mL Single Dose Vials Each 5 mL Vial Contains 500 mg Levetiracetam, 8.2 mg Sodium Acetate Trihydrate, 45 mg Sodium Chloride, Glacial Acetic Acid For Ph Adjustment To 6. Usual Dosage: See Package Insert. Discard Unused Portion. Retain In Carton Until Time Of Use. Store At 25ºc (77ºf); Excursions Permitted To 15º To 30ºc (59º To 86ºf) [see Usp Controlled Room Temperature]. (Levetiracetam Injection Novaplus 10)

This text appears to contain product identification information including a GTIN (Global Trade Item Number), SN (Serial Number), EXP (Expiration Date), and LOT (Lot Number). The specific values for each of these identification fields are not provided.*

FDA Label Image

Figure 1: Responder Rate (≥50% Reduction From Baseline) In Study 1 (Levetiracetam Injection Novaplus 2)

The text is not readable.*

FDA Label Image

Figure 2: Responder Rate (≥50% Reduction From Baseline) In Study 2: Period A (Levetiracetam Injection Novaplus 3)

FDA Label Image

Figure 3: Responder Rate (≥50% Reduction From Baseline) In Study 3 (Levetiracetam Injection Novaplus 4)

FDA Label Image

Figure 4: Responder Rate (≥ 50% Reduction From Baseline) In Study 4 (Levetiracetam Injection Novaplus 5)

This appears to be a table or chart displaying the percentages of individuals in two different groups (placebo and levetiracetam) for some variable or outcome measure. Without additional information or context, it is not possible to determine the specific variable or outcome being measured.*

FDA Label Image

Figure 5: Responder Rate For All Patients Ages 1 Month To < 4 Years (≥ 50% Reduction From Baseline) In Study 5 (Levetiracetam Injection Novaplus 6)

This appears to be a table or graph showing percentages attributed to "Placebo" and "Levetiracetam" with corresponding sample sizes. However, there is not enough context to determine what these percentages and sample sizes represent.*

FDA Label Image

Figure 6: Responder Rate (≥50% Reduction From Baseline) In Pgtc Seizure Frequency Per Week In Study 7 (Levetiracetam Injection Novaplus 7)

FDA Label Image

Ndc 0143-9574-01 Rx Only Levetiracetam Injection For Iv Use Only 500 mg/5 mL (100 mg/ml) Must Be Diluted Prior To Administration 5 mL Single Dose Vial Usual Dosage: See Package Insert. Discard Unused Portion. Retain In Carton Until Time Of Use. Store At 25ºc (77ºf); Excursions Permitted To 15º To 30ºc (59º To 86ºf) [see Usp Controlled Room Tem- Perature]. (Levetiracetam Injection Novaplus 8)

This is a description of Levetiracetam Injection, which is used for IV administration. The injection comes in a 5 ml single-dose vial with a strength of 500 mg per 5 ml. It is recommended to dilute the injection before administration. The usual dosage should be followed, and any unused portion should be discarded. The injection should be stored at a controlled room temperature of 25°C (77°F) but can also be stored between 15°C to 30°C (59°F to 86°F), as permitted by USP. The text includes the manufacturer's name and address, but no other useful information is visible.*

FDA Label Image

Ndc 0143-9574-10 Rx Only Levetiracetam Injection For Iv Use Only 500 mg/5 mL (100 mg/ml) Must Be Diluted Prior To Administration 10 X 5 mL Single Dose Vials Each 5 mL Vial Contains 500 mg Levetiracetam, 8.2 mg Sodium Acetate Trihydrate, 45 mg Sodium Chloride, Glacial Acetic Acid For Ph Adjustment To 6. Usual Dosage: See Package Insert. Discard Unused Portion. Retain In Carton Until Time Of Use. Store At 25ºc (77ºf); Excursions Permitted To 15º To 30ºc (59º To 86ºf) [see Usp Controlled Room Temperature]. (Levetiracetam Injection Novaplus 9)

Levetiracetam Injection is a prescription medication that comes in a 5 mL single-dose vial. The vial contains 500 mg of the active ingredient levetiracetam per 5 mL, which must be diluted before administering. Each vial also contains 8.2 mg of sodium acetate trihydrate, 45 mg of sodium chloride, and glacial acetic acid. The usual dosage is included in the package insert. Unused portions should be discarded, and the medication should be stored at 25°C (77°F) with permissible excursions from 10 to 30°C (59° to 86°F) controlled room temperature. The product is distributed by Hikma in NJ, USA, under the brand name Novaplus™.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.